What is the best antibiotic treatment for gonorrhea?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 22, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Best Antibiotic for Gonorrhea

The best antibiotic treatment for gonorrhea is ceftriaxone 500 mg intramuscularly as a single dose, which should be combined with doxycycline 100 mg orally twice daily for 7 days if chlamydial coinfection has not been excluded. 1

Primary Treatment Regimen

Ceftriaxone 500 mg IM once is now the recommended first-line monotherapy for uncomplicated gonorrhea at all anatomic sites (urogenital, rectal, and pharyngeal). 1 This represents an increase from the previous 250 mg dose based on updated pharmacokinetic/pharmacodynamic data and antimicrobial stewardship principles. 1

Key Changes from Previous Guidelines

  • Azithromycin is no longer routinely recommended as part of dual therapy due to rapidly rising resistance, with nearly 5% of U.S. isolates showing elevated azithromycin MICs (≥2.0 mcg/mL) by 2018. 1
  • The older dual therapy regimen (ceftriaxone 250 mg + azithromycin 1 g) was recommended in 2012-2015 guidelines 2, but resistance patterns have evolved significantly since then.
  • Add doxycycline 100 mg orally twice daily for 7 days only if chlamydial coinfection has not been excluded, as coinfection occurs in 40-50% of gonorrhea cases. 3

Rationale for Current Recommendations

Ceftriaxone remains highly effective with stable resistance patterns in the United States, with <0.1% of isolates showing elevated MICs (>0.25 mcg/mL). 1 The higher 500 mg dose provides:

  • Superior bactericidal levels at all anatomic sites 1
  • Enhanced efficacy against pharyngeal infections, which are notoriously difficult to eradicate 3
  • A buffer against emerging resistance 1

Azithromycin monotherapy (even 2 g) is insufficient, with only 93% efficacy for gonorrhea treatment. 3 The rapid rise in azithromycin resistance makes it unsuitable as a routine component of dual therapy. 1

Alternative Regimens (When Ceftriaxone Unavailable)

If ceftriaxone is not available:

  • Cefixime 400 mg orally once PLUS azithromycin 1 g orally once 2, 3, 4
  • Mandatory test-of-cure at 1 week is required with this regimen 2, 3
  • Cefixime has significantly lower efficacy for pharyngeal gonorrhea (limited effectiveness) and provides less sustained bactericidal levels than ceftriaxone 2, 4

Severe Cephalosporin Allergy

For patients with severe cephalosporin allergy:

  • Gentamicin 240 mg IM once PLUS azithromycin 2 g orally once demonstrates 100% cure rates in clinical trials 3, 5
  • Alternative: Azithromycin 2 g orally once alone (lower efficacy at 93%, high GI side effects) 2, 3
  • Mandatory test-of-cure at 1 week 2, 3

Critical caveat: Gentamicin has poor pharyngeal efficacy (only 20% cure rate), so avoid for pharyngeal infections. 3

Special Populations

Men Who Have Sex with Men (MSM)

  • Use only ceftriaxone 500 mg IM due to higher prevalence of resistant strains in this population 3, 4
  • Never use quinolones (ciprofloxacin, ofloxacin) in MSM due to widespread resistance 3

Pregnant Women

  • Ceftriaxone 500 mg IM once PLUS azithromycin 1 g orally once is the preferred regimen 3, 6, 7
  • Never use quinolones or tetracyclines in pregnancy 3, 4
  • If injection is refused, cefixime 400 mg orally PLUS azithromycin 1 g orally can be considered, though less effective 4

Site-Specific Considerations

Pharyngeal gonorrhea requires special attention as it is significantly more difficult to eradicate than urogenital or anorectal infections. 3

  • Ceftriaxone 500 mg IM is the only reliably effective treatment for pharyngeal infections 3
  • Oral cephalosporins (cefixime) have limited efficacy for pharyngeal disease 2
  • Spectinomycin has only 52% efficacy for pharyngeal infections 3

Critical Pitfalls to Avoid

  • Never use fluoroquinolones (ciprofloxacin, ofloxacin) for gonorrhea treatment due to widespread resistance, despite historical 99.8% cure rates 3
  • Never use azithromycin 1 g alone for gonorrhea treatment (only 93% efficacy) 3, 8
  • Never substitute oral cephalosporins as first-line therapy due to documented treatment failures in Europe 4
  • Do not use spectinomycin or gentamicin for pharyngeal infections due to poor efficacy 3

Follow-Up and Partner Management

Test-of-Cure Requirements

  • Not needed for patients treated with recommended ceftriaxone regimen 6, 7
  • Mandatory at 1 week for patients receiving cefixime or azithromycin monotherapy 2, 3
  • If symptoms persist after treatment, obtain culture with antimicrobial susceptibility testing 3, 4

Partner Management

  • Evaluate and treat all sexual partners from the preceding 60 days 3, 4
  • Partners should receive the same dual therapy regimen 3
  • Retest all patients 3 months after treatment due to high reinfection rates (40-50%) 6, 7

Concurrent Testing

  • Screen for syphilis with serology at time of gonorrhea diagnosis 3, 4
  • Test for HIV given gonorrhea's facilitation of HIV transmission 3
  • Test for chlamydia to guide need for doxycycline 1

Treatment Failure Management

If treatment failure occurs:

  • Obtain specimens for culture and antimicrobial susceptibility testing immediately 3
  • Report to local public health officials within 24 hours 3
  • Consult an infectious disease specialist 3
  • Salvage regimens include gentamicin 240 mg IM PLUS azithromycin 2 g orally, or ertapenem 1 g IM for 3 days 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Gonorrhea Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Gonorrhea Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrhea.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2014

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.